skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Available and emerging treatments for Parkinson’s disease: a review

Review

(3565) Views  (1496) Full article downloads

Authors: Hickey PT, Stacy MA

Published Date May 2011 Volume 2011:5 Pages 241 - 254
DOI: http://dx.doi.org/10.2147/DDDT.S11836

Patrick Hickey, Mark Stacy
Division of Neurology, Duke University Medical Center, Durham, NC, USA

Abstract: Parkinson’s disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective in advanced disease. Deep brain stimulation provides a practicable alternative at this stage, although a minority of patients meet the strict criteria for surgery. Novel medications that provide enhanced symptomatic control remain in developmental demand. Both gene and cell-based therapies have shown promise in early clinical studies. A major unmet need is a treatment that slows or stops disease progression.

Keywords: Parkinson’s disease, levodopa, motor fluctuations, adenosine A2A antagonists, deep brain stimulation, gene therapy




 

Other articles by Professor Mark Stacy



Readers of this article also read:

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
The use of serotonergic drugs to treat obesity – is there any hope?
Drug discovery and development for neglected diseases: the DNDi model
Development of oral immunomodulatory agents in the management of multiple sclerosis
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
Emerging options in growth hormone therapy: an update
Treatment for primary hypothyroidism: current approaches and future possibilities
Use of perfusion index from pulse oximetry to determine efficacy of stellate ganglion block
Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University